New Delhi, February 12 An ICMR study has found that six-month all-oral treatment regimens for multidrug-resistant and rifampicin-resistant tuberculosis are cost-effective and offer improved health outcomes compared to the longer treatment plans currently used in India.The economic evaluation...
bedaquiline
cost-effectiveness
icmr study
linezolid
moxifloxacin
multidrug-resistanttuberculosis
national tuberculosis elimination program
pretomanid
rifampicin-resistant tuberculosistuberculosis treatment